FR2085730A1 - Salicylamide salts for oral administration - Google Patents
Salicylamide salts for oral administrationInfo
- Publication number
- FR2085730A1 FR2085730A1 FR7109961A FR7109961A FR2085730A1 FR 2085730 A1 FR2085730 A1 FR 2085730A1 FR 7109961 A FR7109961 A FR 7109961A FR 7109961 A FR7109961 A FR 7109961A FR 2085730 A1 FR2085730 A1 FR 2085730A1
- Authority
- FR
- France
- Prior art keywords
- salicylamide
- oral administration
- salts
- alkali
- earth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
A dosage unit form suitable for oral administration comprises an alkali(ne earth)metal salt of salicylamide (I) and opt. alkali(ne earth)metal salt of acetominophen (II). (I) is an analgesic, antipyretic and anti-inflammatory agent and the compn. give high blood levels of (I). The ratio of (I):(II) may be 0.25:1 to 40:1. Dosage forms include enteric coated tablets and effervescent compsn. Units doses contain 50-750 mg, esp. 300 mg. (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2204970A | 1970-03-23 | 1970-03-23 | |
US05/077,040 US3946053A (en) | 1970-09-30 | 1970-09-30 | Hydrocarbyl hydrogen phosphate salts of amino-amides |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2085730A1 true FR2085730A1 (en) | 1971-12-31 |
FR2085730B1 FR2085730B1 (en) | 1975-06-06 |
Family
ID=26695421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7109961A Granted FR2085730A1 (en) | 1970-03-23 | 1971-03-22 | Salicylamide salts for oral administration |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2085730A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0011489A1 (en) * | 1978-11-16 | 1980-05-28 | Beecham Group Plc | An analgesic effervescent powder and process for its preparation |
-
1971
- 1971-03-22 FR FR7109961A patent/FR2085730A1/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0011489A1 (en) * | 1978-11-16 | 1980-05-28 | Beecham Group Plc | An analgesic effervescent powder and process for its preparation |
Also Published As
Publication number | Publication date |
---|---|
FR2085730B1 (en) | 1975-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES442579A1 (en) | Effervescent enteric coated L-dopa formulation and method of using the same | |
DE69217191D1 (en) | MULTIPARTICLE TABLET WITH QUICK RESOLUTION | |
ES8307095A1 (en) | Pharmaceutical Formulation. | |
ES491621A0 (en) | PROCEDURE FOR PRODUCING A PHARMACEUTICAL PREPARATION IN THE FORM OF A POLYACRYLATE FILM, SUITABLE FOR APPLICATION VIA TRANSDERMAL. | |
IE42950L (en) | X-ray contrast preparations | |
ES370058A1 (en) | Antibiotic compositions | |
BE827595A (en) | MEDICINAL PRODUCT FOR ORAL ADMINISTRATION PRODUCING AN ANTIPLASMINE INHIBITOR EFFECT | |
FR2085730A1 (en) | Salicylamide salts for oral administration | |
FI49409C (en) | A process for the preparation of pharmacologically active quinuclidine-2- and quinuclidine-3-carboxylic acid anilides and their therapeutically acceptable salts. | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
FR2318649A1 (en) | Treatment for rheumatism and cancer - contg. iodine, iodide, thiosulphate, polyvinyl pyrrolidone, an analgesic and an anaesthetic | |
GB911482A (en) | Pharmaceutical tablets comprising a synergistic combination including salts of ª--phenoxyethyl penicillin | |
FR2081478A1 (en) | Treatment of acne and psoriasis with vitamin - a acids | |
GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
FR1605346A (en) | Sustained release dosage forms | |
AU474505B2 (en) | Pharmaceutical composition containing 2-hydroxy-methyl-3-phenyl-4(3h)-quinazolinone or pharmaceutically acceptable acid salts thereof and method of treatment | |
SU301951A1 (en) | MEDICINE | |
ES377723A1 (en) | Improvements in pharmaceutical compositions | |
NL7104752A (en) | Anti-alcoholic compsns contng calcium 5-buty | |
FR2132601A1 (en) | Anti-alcoholic compsns contng calcium 5-buty | |
BE765809A (en) | Anti-alcoholic compsns contng calcium 5-buty | |
FR2081580A1 (en) | Pharmacol-active 2,4,6-trimethoxybenzoates | |
FR2092024A1 (en) | (+)-beta-amino-beta (3,4-dimethoxy-phenyl)-p - | |
JPS643123A (en) | Remedy for skin inflammation | |
FR2260995A1 (en) | Benzimidazole-contg. medicaments - for treating non-malignant gastroduodenal disorders, esp. ulcers and hypersecretion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TP | Transmission of property | ||
ST | Notification of lapse |